GOLDMAN SACHS GROUP INC - MAXCYTE INC ownership

MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 103 filers reported holding MAXCYTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of MAXCYTE INC
ValueSharesWeighting
Q3 2023$571,072
-24.8%
183,036
+10.7%
0.00%
Q2 2023$759,035
+13.4%
165,367
+22.3%
0.00%
Q1 2023$669,339
-0.3%
135,220
+10.0%
0.00%
Q4 2022$671,253
-77.5%
122,940
-73.2%
0.00%
-100.0%
Q3 2022$2,980,000
-51.3%
458,420
-64.5%
0.00%0.0%
Q2 2022$6,113,000
-12.9%
1,292,242
+28.7%
0.00%0.0%
Q1 2022$7,016,000
+186.5%
1,003,738
+317.5%
0.00%
Q4 2021$2,449,000
+28.3%
240,394
+53.7%
0.00%
Q3 2021$1,909,000156,3830.00%
Other shareholders
MAXCYTE INC shareholders Q2 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 1,885,000$5,881,2005.55%
Vitruvian Partners LLP 5,043,356$15,735,2714.46%
Stonepine Capital Management, LLC 3,761,640$11,736,3173.90%
Mudita Advisors LLP 1,390,858$4,339,4773.17%
RIVER GLOBAL INVESTORS LLP 1,473,254$4,588,3591.07%
Casdin Capital, LLC 1,890,000$5,896,8000.65%
Portolan Capital Management 2,143,666$6,688,2380.62%
Grandeur Peak Global Advisors, LLC 1,434,819$4,476,6350.34%
First Light Asset Management, LLC 1,073,110$3,348,1030.32%
Granahan Investment Management 1,975,847$6,164,6430.22%
View complete list of MAXCYTE INC shareholders